Evaluation of three mRNA markers for the detection of lymph node metastases

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3855-3860

  Berger, Jennifer ^a,b   Mueller Holzner, Elisabeth ^a   Fiegl, Heidi ^a   Marth, Christian ^a   Daxenbichler, Guenter ^a,c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Department of Obstetrics ^*  (Austria)

Author keywords

Breast cancer; Cytokeratin 19; DNA methyltransferase 3b; Lymph node metastases; Mammaglobin; Real time RT PCR

Indexed keywords

CYTOKERATIN 19; MAMMAGLOBIN; MESSENGER RNA; METHYLTRANSFERASE;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA PRIMERS; HUMANS; KERATIN-19; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTEROGLOBIN;

EID: 33750736632     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bonadonna G, Valagussa P, Moliterni A, Zambetti M and Brambilla C: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332: 901-906, 1995.
2. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER and Cruz AB: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983.
3. Holmgren L, O'Reilly MS and Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153, 1995.
4. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D and Contesco G: Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 27: 483-487, 1988.
5. De Mascarel I, Bonichon F, Coindre JM and Trojani M: Prognostic significance of breast cancer axillary lymph node metastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66: 523-527, 1992.
6. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S and Koyama H: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction. Cancer 74: 1595-1600, 1994.
7. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD and Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990, 1994.
8. Masuda N, Tamaki Y, Sakita I, Ooka M, Ohnishi T, Kadota M, Aritake N, Okubo K and Monden M: Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction (RT-PCR) in breast cancer patients. Clin Cancer Res 6: 4176-4185, 2000.
9. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z, Gillanders WE and Cole DJ: Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93: 162-171, 2001.
10. Min CJ, Tafra L and Verbanac KM: Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 58: 4581-4584, 1998.
11. Watson MA and Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is over-expressed in human breast cancer. Cancer Res 56: 860-865, 1996.
12. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R and Fleming TP: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59: 3028-3031, 1999.
13. Grunewald K, Haun M, Urbanek M, Fiegl M, Muller-Holzner E, Gunsilius E, Dunser M, Marth C and Gastl G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth- factor receptor and cytokeratin-19. Lab Invest 80: 1071-1077, 2000.
14. Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA and Jacobs IJ: Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357: 15-20, 2001.
15. Manzotti M, Dell'Orto P, Maisonneuve P, Zurrida S, Mazzarol G and Viale G: Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 95: 307-312, 2001.
16. Schlegel R, Banks-Schlegel S and Pinkus GS: Immunohistochemical localization of keratin in normal human tissues. Lab Invest 42: 91-96, 1980.
17. Okano M, Bell DW, Haber DA and Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257, 1999.
18. Holliday R and Pugh JE: DNA modification mechanisms and gene activity during development. Science 187: 226-232, 1975.
19. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440, 2002.
20. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 3: 223-231, 2005.
21. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298, 1999.
22. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y and Hirohashi S: DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91: 205-212, 2001.
23. Girault I, Tozlu S, Lidereau R and Bieche I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9: 4415-4422, 2003.
24. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB and Vogelstein B: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556, 2002.
25. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 56-159, 1987.
26. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, Hennen G, Grisar T, Igout A and Heinen E: Housekeeping genes as internal standards: use and limits. J Biotechnol 75: 291-295, 1999.
27. Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B and Neville AM: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354: 896-900, 1999.
28. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R and Vidaud M: Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 78: 661-666, 1998.
29. Pellise M, Castells A, Gines A, Agrelo R, Sole M, Castellvi-Bel S, Fernandez-Esparrach G, Llach J, Esteller M, Bordas JM and Pique JM: Detection of lymph node micrometastases by promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin Cancer Res 10: 4444-4449, 2004.
30. Kurahashi T, Hara I, Oka N, Kamidono S, Eto H and Miyake H: Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for focally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11: 3773-3777, 2005.